A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Organon & Co. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 2,102 shares of OGN stock, worth $30,899. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,102
Previous 2,698 22.09%
Holding current value
$30,899
Previous $55,000 27.27%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.65 - $23.03 $11,115 - $13,725
-596 Reduced 22.09%
2,102 $40,000
Q2 2024

Aug 14, 2024

SELL
$17.45 - $21.96 $7,625 - $9,596
-437 Reduced 13.94%
2,698 $55,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $43,200 - $58,938
3,135 New
3,135 $58.9 Million
Q4 2023

Aug 14, 2024

BUY
$10.95 - $17.32 $9,887 - $15,639
903 Added 35.83%
3,423 $49.4 Million
Q3 2023

Aug 14, 2024

SELL
$16.59 - $23.77 $4,678 - $6,703
-282 Reduced 10.06%
2,520 $43.7 Million
Q2 2023

Aug 14, 2024

SELL
$19.27 - $24.63 $2,023 - $2,586
-105 Reduced 3.61%
2,802 $58.3 Million
Q1 2023

Aug 14, 2024

SELL
$21.42 - $32.08 $4,498 - $6,736
-210 Reduced 6.74%
2,907 $68.4 Million
Q4 2022

Aug 14, 2024

SELL
$23.31 - $28.61 $1,794 - $2,202
-77 Reduced 2.41%
3,117 $87.1 Million
Q3 2022

Aug 14, 2024

SELL
$23.4 - $34.25 $5,873 - $8,596
-251 Reduced 7.29%
3,194 $74.7 Million
Q2 2022

Aug 14, 2024

SELL
$31.66 - $38.9 $9,498 - $11,670
-300 Reduced 8.01%
3,445 $116 Million
Q1 2022

Aug 14, 2024

BUY
$30.45 - $39.36 $31,881 - $41,209
1,047 Added 38.81%
3,745 $131 Million
Q4 2021

Aug 30, 2024

SELL
$28.67 - $37.13 $71,933 - $93,159
-2,509 Reduced 37.05%
4,263 $130 Million
Q3 2021

Aug 30, 2024

SELL
$28.63 - $35.64 $135,591 - $168,791
-4,736 Reduced 41.15%
6,772 $222 Million
Q2 2021

Aug 30, 2024

BUY
$28.45 - $38.0 $250,644 - $334,780
8,810 Added 326.54%
11,508 $348 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.74B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.